Methods and compositions for producing artificial fascia

• US 6,482,645 B2
• Filed: 03/05/2002
• Issued: 11/19/2002
• Est. Priority Date: 12/29/1999
• Status: Expired due to Fees

• Current Assignee: Children's Medical Center Corporation
• Original Assignee: Children's Medical Center Corporation
• Inventors: Atala, Anthony
• Primary Examiner(s): Lankford, Jr., Leon B.
• Application Number:
  US10/090,892
• Publication Number:
  US 20020094570A1
• Time in Patent Office: 259 Days
• Field of Search: 435/395, 435/398, 435/401, 435/402, 128/885, 128/898, 424/93.7, 623/11.11
• US Class Current: 435/395
• CPC Class Codes: A61L 27/3804 characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
• CPC Class Codes: A61L 27/3839 characterised by the site of application in the body materials for artificial blood vessels A61L27/507; materials for use in artificial skin A61L27/60
• CPC Class Codes: A61L 27/3891 as distinct cell layers
• CPC Class Codes: A61L 31/005 Ingredients of undetermined constitution or reaction products thereof

Abstract

The present invention describes methods for producing artificial fascial slings and their subsequent use in treating subjects with urinary incontinence. The invention is based, in part, on the discovery that mesenchymal cells that secrete elastin and collagen, extracellular proteins responsible for elasticity and strength, respectively, can be used to engineer artificial fascia in vitro.

Claims

1. An artificial fascia comprising:

a polylayer of collagen-secreting cells derived from a cultured cell population on a biocompatible substrate; and

a polylayer of elastin-secreting cells derived from a second cultured cell population on the polylayer of the collagen-secreting cell population, such that the cells of the two different populations form a chimeric interface.

2. The artificial fascia of claim 1, further comprising a fibroblast polylayer derived from a cultured fibroblast cell population such that the fibroblast polylayer forms the chimeric interface with the polylayer of collagen secreting cells.

3. The artificial fascia of claim 1, further comprising selecting a biocompatable substrate from the group consisting of cellulose ether, cellulose, cellulosic ester, fluorinated polyethylene, phenolic, poly-4-methylpentene, polyacrylonitrile, polyamide, polyamideimide, polyacrylate, polybenzoxazole, polycarbonate, polycyanoarylether, polyester, polyestercarbonate, polyether, polyetheretherketone, polyetherimide, polyetherketone, polyethersulfone, polyethylene, polyfluoroolefin, polymide, polyolefin, polyoxadiazole, polyphenylene oxide, polyphenylene, sulfide, polypropylene, polystyrene, polysulfide, polysulfone, polytetrafluoroethylene, polythioether, polytriazole, polyurethane, polyvinylidene fluoride, regenerated cellulose, urea-formaldehyde, or copolymers or physical blends thereof.

4. The artificial fascia of claim 1, further comprising selecting a polyglycolic acid biocompatable substrate.

5. The artificial fascia of claim 1, wherein the collagen-secreting cells are selected from the group consisting of fibroblasts, chondroblasts, osteoblasts, and odontoblasts.

6. The artificial fascia of claim 1, wherein the elastin-secreting cells are selected from the group consisting of smooth muscle cells, chondrocytes, and fibroblasts.

7. An artificial fascia comprising:

a polylayer of a collagen-secreting cells derived from a cultured cell population on a first surface of a biocompatible substrate; and

a polylayer of elastin-secreting cells derived from a second cultured cell population on a second surface of the biocompatible substrate, wherein the second surface is opposite the first surface.

8. The artificial fascia of claim 7 further comprising a fibroblast polylayer derived from a cultured fibroblast cell population such that the fibroblast polylayer forms a chimeric interface with at least one polylayer selected from the group consisting of a collagen polylayer or an elastin polylayer.

9. The artificial fascia of claim 7, further comprising selecting a biocompatable substrate from the group consisting of cellulose ether, cellulose, cellulosic ester, fluorinated polyethylene, phenolic, poly-4-methylpentene, polyacrylonitrile, polyamide, polyamideimide, polyacrylate, polybenzoxazole, polycarbonate, polycyanoarylether, polyester, polyestercarbonate, polyether, polyetheretherketone, polyetherimide, polyetherketone, polyethersulfone, polyethylene, polyfluoroolefin, polymide, polyolefin, polyoxadiazole, polyphenylene oxide, polyphenylene, sulfide, polypropylene, polystyrene, polysulfide, polysulfone, polytetrafluoroethylene, polythioether, polytriazole, polyurethane, polyvinylidene fluoride, regenerated cellulose, urea-formaldehyde, or copolymers or physical blends thereof.

10. The artificial fascia of claim 7, further comprising selecting a polyglycolic acid biocompatable substrate.

11. The artificial fascia of claim 7, wherein the collagen-secreting cells are selected from the group consisting of fibroblasts, chondroblasts, osteoblasts, and odontoblasts.

12. The artificial fascia of claim 7, wherein the elastin-secreting cells are from the group consisting of smooth muscle cells, chondrocytes, and fibroblasts.

13. A method for producing an artificial fascia comprising:

creating a polylayer of collagen-secreting cells derived from a cultured cell population on a biocompatible substrate; and

creating a polylayer of elastin-secreting cells derived from a second cultured cell population on the polylayer of the collagen-secreting cell population, such that the cells of the two different populations form a chimeric interface.

14. The method of claim 13, wherein the method further comprises creating a fibroblast polylayer derived from a cultured fibroblast cell population such that the fibroblast polylayer forms the chimeric interface with the polylayer of collagen secreting cells.

15. The method of claim 13, further comprising selecting a biocompatable substrate from the group consisting of cellulose ether, cellulose, cellulosic ester, fluorinated polyethylene, phenolic, poly-4-methylpentene, polyacrylonitrile, polyamide, polyamideimide, polyacrylate, polybenzoxazole, polycarbonate, polycyanoarylether, polyester, polyestercarbonate, polyether, polyetheretherketone, polyetherimide, polyetherketone, polyethersulfone, polyethylene, polyfluoroolefin, polymide, polyolefin, polyoxadiazole, polyphenylene oxide, polyphenylene, sulfide, polypropylene, polystyrene, polysulfide, polysulfone, polytetrafluoroethylene, polythioether, polytriazole, polyurethane, polyvinylidene fluoride, regenerated cellulose, urea-formaldehyde, or copolymers or physical blends thereof.

16. The method of claim 13, further comprising selecting a polyglycolic acid biocompatable substrate.

17. The method of claim 13, wherein the collagen-secreting cells are selected from the group consisting of fibroblasts, chondroblasts, osteoblasts, and odontoblasts.

18. The method of claim 13, wherein the elastin-secreting cells are selected from the group consisting of smooth muscle cells, chondrocytes, and fibroblasts.

19. A method for producing an artificial fascia comprising:

creating a polylayer of a collagen-secreting cells derived from a cultured cell population on a first surface of a biocompatible substrate; and

creating a polylayer of elastin-secreting cells derived from a second cultured cell population on a second surface of the biocompatible substrate, wherein the second surface is opposite the first surface.

20. The method of claim 19, wherein the method further comprises creating a fibroblast polylayer derived from a cultured fibroblast cell population such that the fibroblast polylayer forms a chimeric interface with at least one polylayer selected from the group consisting of a collagen polylayer or an elastin polylayer.

21. The method of claim 19, further comprising selecting a biocompatable substrate from the group consisting of cellulose ether, cellulose, cellulosic ester, fluorinated polyethylene, phenolic, poly4-methylpentene, polyacrylonitrile, polyamide, polyamideimide, polyacrylate, polybenzoxazole, polycarbonate, polycyanoarylether, polyester, polyestercarbonate, polyether, polyetheretherketone, polyetherimide, polyetherketone, polyethersulfone, polyethylene, polyfluoroolefin, polymide, polyolefin, polyoxadiazole, polyphenylene oxide, polyphenylene, sulfide, polypropylene, polystyrene, polysulfide, polysulfone, polytetrafluoroethylene, polythioether, polytriazole, polyurethane, polyvinylidene fluoride, regenerated cellulose, urea-formaldehyde, or copolymers or physical blends thereof.

22. The method of claim 19, further comprising selecting a polyglycolic acid biocompatable substrate.

23. The method of claim 19, wherein the collagen-secreting cells are selected from the group consisting of fibroblasts, chondroblasts, osteoblasts, and odontoblasts.

24. The method of claim 19, wherein the elastin-secreting cells are from the group consisting of smooth muscle cells, chondrocytes, and fibroblasts.